| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615105 | Journal of Clinical Lipidology | 2017 | 23 Pages |
Abstract
Truncating APOB mutations showed the more striking low-density lipoprotein cholesterol lowering effect compared with p.S17* mutation in ANGPTL3. Reduced high-density lipoprotein cholesterol levels were the unique lipid characteristic associated with FHBL2. Mutations impairing liver synthesis or secretion of apolipoprotein B are crucial to increase the risk of liver steatosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alessia PhD, Enza PhD, Davide MD, PhD, Angelo Baldassare MD, PhD, Ilenia PhD, Luca BSc, Laura MD, PhD, Vito MD, Rossella PhD, Patrizia PhD, Maurizio MD, Marcello MD,